Zynex, Inc. Stock News

Zynex Inc (NASDAQ:ZYXI), a medical technology company specializing in non-invasive devices for pain management, rehabilitation, and patient monitoring, announced the arrival of Steven Dyson as its new CEO, along with the appointment of several senior leaders. The company announced back in June that Dyson had been selected as incoming CEO.

ENGLEWOOD, Colo. , Aug. 18, 2025 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today announced the arrival of newly appointed CEO, Steven Dyson, and the appointment of several new leaders at the Company.

Investors can contact the law firm at no cost to learn more about recovering their losses

NEW YORK, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Zynex, Inc. (NASDAQ:ZYXI) on behalf of long-term stockholders following a class action complaint that was filed against Zynex on July 9, 2025 with a Class Period from March 13, 2023, to the present. Our investigation concerns whe...

Zynex Q2 Revenue Drops 55%

Zynex, Inc. (NASDAQ:ZYXI ) Q2 2025 Earnings Conference Call July 31, 2025 4:15 PM ET Company Participants Anna Lucsok - Chief Operating Officer Daniel J. Moorhead - Chief Financial Officer Donald Gregg - President of Zynex Monitoring Solutions Thomas Sandgaard - Founder, President, CEO & Chairman Conference Call Participants Jeffrey Scott Cohen - Ladenburg Thalmann & Co. Inc., Research Division...

Zynex Inc (NASDAQ:ZYXI), a developer of non-invasive medical devices, is laying the foundation for a return to growth following a pivotal second quarter marked by leadership changes, operational streamlining, and a key FDA submission for its next-generation pulse oximeter. The company appointed industry veteran Steven Dyson as CEO in Q2, a move founder Thomas Sandgaard called “transformational”...

ENGLEWOOD, Colo. , July 31, 2025 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today reported its financial and operational results for the second quarter ended June 30, 2025.